Publications by authors named "Yoshiharu Matsuura"

Introduction: The SARS-CoV-2 pandemic has had a widespread and severe impact on society, yet there have also been instances of remarkable recovery, even in critically ill patients.

Materials And Methods: In this study, we used single-cell RNA sequencing to analyze the immune responses in recovered and deceased COVID-19 patients during moderate and critical stages.

Results: Expanded T cell receptor (TCR) clones were predominantly SARS-CoV-2-specific, but represented only a small fraction of the total repertoire in all patients.

View Article and Find Full Text PDF

We previously reported that hepatitis C virus (HCV) infection or HCV core protein expression induces HOX gene expression by impairing histone H2A monoubiquitination via a proteasome-dependent reduction in the level of RNF2, a key catalytic component of polycomb repressive complex 1 (H. Kasai, K. Mochizuki, T.

View Article and Find Full Text PDF

Whereas severe COVID-19 is often associated with elevated autoantibody titers, the underlying mechanism behind their generation has remained unclear. Here we report clonal composition and diversity of autoantibodies in humoral response to SARS-CoV-2. Immunoglobulin repertoire analysis and characterization of plasmablast-derived monoclonal antibodies uncovered clonal expansion of plasmablasts producing cardiolipin (CL)-reactive autoantibodies.

View Article and Find Full Text PDF

Coronavirus (CoV) possesses numerous functional cis-acting elements in its positive-strand genomic RNA. Although most of these RNA structures participate in viral replication, the functions of RNA structures in the genomic RNA of CoV in viral replication remain unclear. In this study, we investigated the functions of the higher-order RNA stem-loop (SL) structures SL5B, SL5C, and SL5D in the ORF1a coding region of Middle East respiratory syndrome coronavirus (MERS-CoV) in viral replication.

View Article and Find Full Text PDF

Flaviviridae is a family of positive-stranded RNA viruses, including human pathogens, such as Japanese encephalitis virus (JEV), dengue virus (DENV), Zika virus (ZIKV), and West Nile virus (WNV). Nuclear localization of the viral core protein is conserved among Flaviviridae, and this feature may be targeted for developing broad-ranging anti-flavivirus drugs. However, the mechanism of core protein translocation to the nucleus and the importance of nuclear translocation in the viral life cycle remain unknown.

View Article and Find Full Text PDF
Article Synopsis
  • SARS-CoV-2 causes a range of respiratory symptoms, and although research has made strides in understanding the virus, many aspects of its infection process are still not fully understood.
  • The study focuses on the interferon-inducible protein ISG15, which is involved in suppressing viral functions through a process called ISGylation, and how SARS-CoV-2's protease, PLpro, interferes with this process.
  • Results show that ISGylation of the SARS-CoV-2 nucleocapsid protein disrupts viral replication, indicating that the virus has evolved mechanisms to evade ISGylation to enhance its own replication efficiency.
View Article and Find Full Text PDF

Enteroviruses are single-stranded, positive-sense RNA viruses causing endoplasmic reticulum (ER) stress to induce or modulate downstream signaling pathways known as the unfolded protein responses (UPR). However, viral and host factors involved in the UPR related to viral pathogenesis remain unclear. In the present study, we aimed to identify the major regulator of enterovirus-induced UPR and elucidate the underlying molecular mechanisms.

View Article and Find Full Text PDF

Monitoring viral dynamics can improve our understanding of pathogenicity and tissue tropism. Because the gene size of RNA viruses is typically small, NanoLuc is the primary choice for accommodation within viral genome. However, NanoLuc/Furimazine and also the conventional firefly luciferase/D-luciferin are known to exhibit relatively low tissue permeability and thus less sensitivity for visualization of deep tissue including lungs.

View Article and Find Full Text PDF

Coronavirus disease 2019 (COVID-19) induces respiratory dysfunction as well as kidney injury. Although the kidney is considered a target organ of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and affected by the COVID-19-induced cytokine storm, the mechanisms of renal reaction in SARS-CoV-2 infection are unknown. In this study, a murine COVID-19 model was induced by nasal infection with mouse-adapted SARS-CoV-2 (MA10).

View Article and Find Full Text PDF
Article Synopsis
  • Novel respiratory viruses can lead to pandemics and may evolve to coexist with humans, as seen with the Omicron variant of SARS-CoV-2 which has spread globally since late 2021.
  • Omicron is less invasive in the lungs and causes milder disease compared to earlier strains mainly due to increased immunity from infections and vaccinations, as well as changes in the virus itself.
  • A study using a low-volume inoculation system on hamsters found that Omicron spreads less efficiently in the lungs than the original Wuhan strain, with specific viral genes influencing this limited spread.
View Article and Find Full Text PDF

Subunit vaccines are among the most useful vaccine modalities; however, their low immunogenicity necessitates the addition of adjuvants. Although adjuvants improve immune responses induced by vaccines, they often cause adverse reactions. To address this, we developed an adjuvant-free subunit vaccine platform that uses pre-existing antibodies generated from past infections or vaccinations as carriers for the delivery of vaccine antigens.

View Article and Find Full Text PDF
Article Synopsis
  • SARS-CoV-2 uses host proteases, particularly furin, to cleave its spike (S) protein for entering cells, with mutations affecting this cleavage potentially influencing the virus's replication and pathogenicity.
  • Two adapted strains of SARS-CoV-2 showed faster viral growth and more effective S protein cleavage while displaying lower pathogenicity than the wild-type strain, suggesting that excessive cleavage might reduce virulence.
  • The findings indicate that the high-growth adapted strains could serve as a basis for developing a low-cost inactivated vaccine, which may provide protection against various SARS-CoV-2 variants.
View Article and Find Full Text PDF
Article Synopsis
  • Even though the COVID-19 pandemic is no longer a worldwide crisis, the disease is still around and new variants keep appearing.
  • Scientists are studying a special antibody called CSW1-1805 that can fight the virus by attaching to a specific part of its spike protein.
  • This antibody can stop several versions of the virus and has been shown to protect mice from getting infected, which helps researchers find new ways to create treatments for COVID-19.
View Article and Find Full Text PDF
Article Synopsis
  • SARS-CoV-2 enters host cells through the spike receptor-binding domain (RBD) interacting with angiotensin-converting enzyme 2 (ACE2).
  • Certain human antibodies targeting the spike N-terminal domain (NTD) can increase ACE2 binding and enhance infection, acting differently than traditional antibody-dependent enhancement mechanisms.
  • The study provides structural models and evidence showing that these NTD-targeting infection-enhancing antibodies (NIEAs) work by crosslinking spike proteins, improving our understanding of their role in SARS-CoV-2 infection.
View Article and Find Full Text PDF

Effective early-stage markers for predicting which patients are at risk of developing SARS-CoV-2 infection have not been fully investigated. Here, we performed comprehensive serum metabolome analysis of a total of 83 patients from two cohorts to determine that the acceleration of amino acid catabolism within 5 days from disease onset correlated with future disease severity. Increased levels of de-aminated amino acid catabolites involved in the de novo nucleotide synthesis pathway were identified as early prognostic markers that correlated with the initial viral load.

View Article and Find Full Text PDF

Intranasal vaccines are anticipated to be powerful tools for combating many infectious diseases, including SARS-CoV-2, because they induce not only systemic immunity but also mucosal immunity at the site of initial infection. However, they are generally inefficient in inducing an antigen-specific immune response without adjuvants. Here, we developed an adjuvant-free intranasal vaccine platform that utilizes the preexisting immunity induced by previous infection or vaccination to enhance vaccine effectiveness.

View Article and Find Full Text PDF
Article Synopsis
  • Using hypochlorous acid (HClO) can help stop the spread of viruses during a pandemic.
  • A special kind of HClO called Hp-SA-HAW was found to be effective against many viruses, like the flu and COVID-19.
  • The way it works is by making viral proteins clump together, which stops the viruses from being able to infect people.
View Article and Find Full Text PDF

Extracellular vesicles (EVs) are lipid membrane-enclosed particles produced by most cells, playing important roles in various biological processes. They have been shown to be involved in antiviral mechanisms such as transporting antiviral molecules, transmitting viral resistance, and participating in antigen presentation. While viral transmission was traditionally thought to occur through independent viral particles, the process of viral infection is complex, with multiple barriers and challenges that viruses must overcome for successful infection.

View Article and Find Full Text PDF
Article Synopsis
  • SARS-CoV-2 and dengue virus (DENV) are causing major health issues globally, with millions of new cases each year and a lack of effective treatments available.
  • Researchers discovered that 2-thiouridine (s2U) is a promising antiviral compound that can combat various positive-sense single-stranded RNA viruses, including DENV and SARS-CoV-2 variants like Omicron.
  • In animal studies, s2U showed potential in inhibiting viral RNA replication, leading to improved survival rates for mice infected with these viruses, highlighting its potential as a broad-spectrum antiviral agent.
View Article and Find Full Text PDF

The Kelch-like ECH-associated protein 1 (Keap1)/NF-E2-related factor 2 (Nrf2)/antioxidant response element (ARE) signaling pathway is one of the most important defense mechanisms against oxidative stress. We previously reported that a cellular hydrogen peroxide scavenger protein, peroxiredoxin 1, a target gene of transcription factor Nrf2, acts as a novel HBV X protein (HBx)-interacting protein and negatively regulates hepatitis B virus (HBV) propagation through degradation of HBV RNA. This study further demonstrates that the Nrf2/ARE signaling pathway is activated during HBV infection, eventually leading to the suppression of HBV replication.

View Article and Find Full Text PDF
Article Synopsis
  • Vaccinations can lessen the severity of COVID-19, but SARS-CoV-2 remains a global health issue; nasal vaccines could be more effective at preventing infections in the upper respiratory tract compared to traditional injections.
  • A study showed that mice receiving the nasal vaccine mounted a stronger local immune response (higher IgA levels) in the nasal area compared to those receiving a subcutaneous vaccine, although systemic IgG levels were higher with the injection.
  • The research indicates that an intranasal inactivated whole-virion vaccine could be a promising approach for enhancing protection against COVID-19 infections, particularly in the upper respiratory tract.
View Article and Find Full Text PDF
Article Synopsis
  • The Omicron variant of SARS-CoV-2 evolves to evade immunity from vaccines and prior infections, leading to the emergence of subvariants that escape current antibody treatments.
  • An engineered ACE2 decoy shows effectiveness in neutralizing various Omicron subvariants and does not lead to the development of viral escape mutants.
  • Inhalation of aerosolized ACE2 decoys has proven beneficial in rodent models and macaques, suggesting this method could enhance COVID-19 treatment efficacy without invasive procedures.
View Article and Find Full Text PDF
Article Synopsis
  • The Lujo virus (LUJV) is a dangerous pathogen associated with hemorrhagic fever and there are currently no effective treatments available for it.
  • Researchers tested approved FDA drugs to find new antiviral options and discovered that certain cannabinoid receptor 1 (CB1) antagonists, like rimonabant, AM251, and AM281, can effectively inhibit LUJV entry into cells.
  • These CB1 antagonists not only blocked the virus's ability to fuse with cell membranes but also reduced the infection rate of LUJV in lab settings, highlighting their potential as candidates for future treatment developments.
View Article and Find Full Text PDF

Annexins (ANXs) comprise a family of calcium- and phospholipid-binding proteins and are implicated in the hepatitis C virus (HCV) life cycle. Here, we demonstrate a novel role of ANX5 in the HCV life cycle. Comparative analysis by quantitative PCR in human hepatoma cells revealed that ANX2, ANX4, and ANX5 were highly expressed among the ANX family proteins.

View Article and Find Full Text PDF

Mutations continue to accumulate within the SARS-CoV-2 genome, and the ongoing epidemic has shown no signs of ending. It is critical to predict problematic mutations that may arise in clinical environments and assess their properties in advance to quickly implement countermeasures against future variant infections. In this study, we identified mutations resistant to remdesivir, which is widely administered to SARS-CoV-2-infected patients, and discuss the cause of resistance.

View Article and Find Full Text PDF